Loading clinical trials...
Loading clinical trials...
An Open Label Study to Document the Treatment Effect of 1 and 2% BPX-01 Minocycline Topical Gel in Moderate to Severe Inflammatory Non-nodular Acne Vulgaris (Protocol Number BPX-01-C04)
Conditions
Interventions
Minocycline
Locations
2
United States
Study Center
Coral Gables, Florida, United States
Study Center
Las Vegas, Nevada, United States
Start Date
March 13, 2017
Primary Completion Date
June 1, 2018
Completion Date
June 1, 2018
Last Updated
July 26, 2022
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT07348978
Lead Sponsor
BioPharmX, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions